Cargando…
NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients
Neurofilament, light polypeptide (NEFL) was demonstrated to be ectopically expressed in breast cancer tissues and decreased in lymph node metastases compared to the paired primary breast cancers in our previous study. Moreover, in several studies, NEFL was regarded as a tumor suppressor gene, and it...
Autores principales: | Li, Xiao-Qing, Li, Lin, Xiao, Chun-Hua, Feng, Yu-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271096/ https://www.ncbi.nlm.nih.gov/pubmed/22319610 http://dx.doi.org/10.1371/journal.pone.0031146 |
Ejemplares similares
-
Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis
por: Ishtiaq, Muhammad, et al.
Publicado: (2014) -
Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy
por: Sainio, Markus T., et al.
Publicado: (2018) -
Association of NEFL Gene Polymorphisms with Wilms' Tumor Susceptibility in Chinese Children
por: Jia, Wei, et al.
Publicado: (2019) -
Phenotypic heterogeneity in patients with NEFL‐related Charcot–Marie–Tooth disease
por: Kim, Hye Jin, et al.
Publicado: (2022) -
The first Portuguese family with NEFL-related Charcot-Marie-Tooth type 2 disease
por: MACHADO, RITA, et al.
Publicado: (2019)